TOSI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 27.127
EU - Europa 13.375
AS - Asia 10.552
SA - Sud America 1.478
AF - Africa 195
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 17
Totale 52.781
Nazione #
US - Stati Uniti d'America 26.888
GB - Regno Unito 4.513
IT - Italia 3.788
CN - Cina 3.536
SG - Singapore 2.979
HK - Hong Kong 1.679
SE - Svezia 1.305
BR - Brasile 1.206
DE - Germania 865
RU - Federazione Russa 618
TR - Turchia 572
UA - Ucraina 564
VN - Vietnam 529
FI - Finlandia 404
FR - Francia 313
KR - Corea 313
BG - Bulgaria 220
IN - India 213
ID - Indonesia 141
NL - Olanda 138
CA - Canada 116
AR - Argentina 101
JP - Giappone 94
ES - Italia 87
IE - Irlanda 86
BD - Bangladesh 74
BE - Belgio 74
ZA - Sudafrica 73
MX - Messico 71
PL - Polonia 69
RO - Romania 68
IQ - Iraq 65
LT - Lituania 60
EC - Ecuador 46
IR - Iran 45
CH - Svizzera 41
PK - Pakistan 41
IL - Israele 40
MY - Malesia 35
CO - Colombia 34
AE - Emirati Arabi Uniti 33
EG - Egitto 31
AT - Austria 26
AU - Australia 25
MA - Marocco 24
UZ - Uzbekistan 23
VE - Venezuela 22
CZ - Repubblica Ceca 21
GR - Grecia 20
EE - Estonia 18
PY - Paraguay 18
CL - Cile 17
PT - Portogallo 17
UY - Uruguay 15
AZ - Azerbaigian 14
EU - Europa 14
DZ - Algeria 12
KZ - Kazakistan 12
TN - Tunisia 12
TW - Taiwan 12
JO - Giordania 11
NZ - Nuova Zelanda 11
SN - Senegal 11
SA - Arabia Saudita 10
BO - Bolivia 9
HU - Ungheria 9
KE - Kenya 9
NO - Norvegia 9
AL - Albania 8
DK - Danimarca 8
PE - Perù 8
CR - Costa Rica 7
JM - Giamaica 7
KG - Kirghizistan 7
AM - Armenia 6
LA - Repubblica Popolare Democratica del Laos 6
LK - Sri Lanka 6
NP - Nepal 6
OM - Oman 6
PH - Filippine 6
TH - Thailandia 6
BZ - Belize 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
BY - Bielorussia 4
KH - Cambogia 4
LV - Lettonia 4
LY - Libia 4
MD - Moldavia 4
MK - Macedonia 4
YE - Yemen 4
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
NG - Nigeria 3
Totale 52.734
Città #
Southend 3.452
Santa Clara 2.622
Fairfield 2.221
Ashburn 2.166
Singapore 1.775
Chandler 1.671
Hong Kong 1.652
Woodbridge 1.618
Hefei 1.272
Jacksonville 1.139
Chicago 1.083
Houston 1.005
Seattle 963
Wilmington 937
Dearborn 876
Ann Arbor 776
Nyköping 761
Cambridge 747
Los Angeles 689
Beijing 640
London 596
Modena 541
Salt Lake City 393
Izmir 326
New York 268
Seoul 252
Dallas 235
Princeton 235
Sofia 215
The Dalles 210
Council Bluffs 203
San Diego 201
Eugene 200
Milan 195
Ho Chi Minh City 189
Helsinki 172
Tampa 170
Bologna 168
Elk Grove Village 167
Moscow 162
Rome 146
Shanghai 127
Buffalo 125
Munich 124
Redwood City 121
São Paulo 115
Jakarta 109
Hanoi 105
Bremen 94
Falls Church 93
Lancaster 91
Des Moines 84
Fremont 84
Frankfurt am Main 80
Reggio Emilia 80
Sterling 79
Tokyo 77
Dublin 72
Columbus 69
Miami 68
Phoenix 67
Brussels 65
Parma 60
Dulles 53
Florence 52
Orem 52
San Jose 50
Guangzhou 48
Naples 48
Stockholm 47
Warsaw 47
Brooklyn 46
Boardman 45
Detroit 45
Nanjing 44
Como 41
Atlanta 40
Denver 39
Tulare 39
Chennai 38
Johannesburg 38
Napoli 37
Norwalk 37
Rio de Janeiro 34
Catania 33
Turin 33
Kunming 32
Montreal 32
Kent 30
Bari 29
Padova 29
Poplar 29
Zhengzhou 29
Baghdad 28
Redondo Beach 28
Turku 28
Belo Horizonte 27
Boston 26
Haiphong 26
Palermo 26
Totale 36.683
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 513
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 457
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 444
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 429
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 408
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 401
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 395
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 392
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 389
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 389
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 385
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 383
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 382
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 377
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 371
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 370
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 369
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 364
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 361
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 354
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 351
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 348
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 348
Chemo-enzymatic synthesis of levodropropizine 348
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 347
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 346
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 345
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 339
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 338
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 336
Vegetable cells in Papanicolaou-stained cervical smears 334
Nanomedicine: the future for advancing medicine and neuroscience 334
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 331
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 329
Polymeric nanoparticles for the drug delivery to the central nervous system 326
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 322
Brain targeting with polymeric nanoparticles: which administration route should we take? 319
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 319
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 315
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 315
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 313
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 312
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 312
Nanoparticle transport across the blood brain barrier 308
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 306
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 306
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 302
Protein corona and nanoparticles: How can we investigate on? 302
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 301
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 298
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 297
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 297
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 294
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 293
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 292
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 291
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 284
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 282
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 281
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 281
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 279
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 278
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 277
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 277
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 274
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 273
Colloidal systems for CNS drug delivery 270
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 270
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 268
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 268
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 266
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 265
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 265
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 261
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 260
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 259
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 258
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 258
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 257
Functionalization of liposomes: microscopical methods for preformulative screening 256
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 255
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 254
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 253
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 250
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 249
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 249
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 247
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 246
Ketorolac tromethamine liposomes: Encapsulation and release studies 240
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 238
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 236
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 235
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 235
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 228
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 227
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 225
Brain targeting by engineered nanoparticles 224
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 223
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 222
Totale 30.717
Categoria #
all - tutte 210.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.098 0 0 0 0 0 353 459 655 255 834 313 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202611.910 1.308 808 1.504 2.778 4.373 1.139 0 0 0 0 0 0
Totale 53.178